{"id":9624,"date":"2026-02-19T10:50:00","date_gmt":"2026-02-19T02:50:00","guid":{"rendered":"https:\/\/fotonmedix.com\/?p=9624"},"modified":"2026-02-04T17:14:51","modified_gmt":"2026-02-04T09:14:51","slug":"the-systemic-frontier-clinical-efficacy-of-high-power-photobiomodulation-in-managing-canine-chronic-kidney-disease","status":"publish","type":"post","link":"https:\/\/fotonmedix.com\/ko\/the-systemic-frontier-clinical-efficacy-of-high-power-photobiomodulation-in-managing-canine-chronic-kidney-disease.html","title":{"rendered":"\uc2dc\uc2a4\ud15c\uc801 \ud504\ub860\ud2f0\uc5b4: \uac1c \ub9cc\uc131 \uc2e0\uc7a5 \uc9c8\ud658 \uad00\ub9ac\uc5d0 \uc788\uc5b4 \uace0\ucd9c\ub825 \uad11\uc0dd\uccb4\uc870\uc808\uc758 \uc784\uc0c1\uc801 \ud6a8\ub2a5"},"content":{"rendered":"

The veterinary medical paradigm is currently expanding beyond the traditional boundaries of musculoskeletal and dermatological care. While the use of veterinary lasers has become the standard for treating orthopedic inflammation, a new clinical frontier is emerging in the management of internal organ dysfunction, specifically Chronic Kidney Disease (CKD) in geriatric patients. As a medical laser clinical expert with two decades of experience, I have observed the shift from utilizing light solely for “surface” healing to its application as a powerful metabolic modulator for deep visceral organs.<\/p>\n\n\n\n

\uc2e4\ubb34\uc790\uac00 \ud3c9\uac00\ud560 \ub54c \ubc18\ub824\uacac\uc744 \uc704\ud55c \ucd5c\uace0\uc758 \uc801\uc0c9\uad11 \uce58\ub8cc\uae30<\/a>, \uc744 \uc12d\ucde8\ud558\ub294 \uc0ac\ub78c\ub4e4\uc740 \ud53c\uc0c1\uc801\uc778 \uac74\uac15 \ud6a8\ub2a5\uc744 \ub118\uc5b4 \ub124\ud504\ub860\uc758 \uc0dd\uccb4 \uc5d0\ub108\uc9c0 \uc694\uad6c \uc0ac\ud56d\uc744 \uc0b4\ud3b4\ubd10\uc57c \ud569\ub2c8\ub2e4. \uc2e0\uc7a5\uc740 \ud3ec\uc720\ub958 \uc2e0\uccb4\uc5d0\uc11c \ubbf8\ud1a0\ucf58\ub4dc\ub9ac\uc544\uac00 \uac00\uc7a5 \ubc00\uc9d1\ub41c \uae30\uad00 \uc911 \ud558\ub098\uc774\ubbc0\ub85c \ub2e4\uc74c\uacfc \uac19\uc740 \uc774\uc0c1\uc801\uc778 \ub300\uc0c1\uc785\ub2c8\ub2e4. \uad11\uc0dd\uccb4\uc870\uc808<\/a> (PBM). \uadf8\ub7ec\ub098 \uc694\ucd94 \uadfc\uc721\uc744 \ud1b5\ud574 \uc2e0\uc7a5 \ud53c\uc9c8\uc5d0 \ub3c4\ub2ec\ud558\ub824\uba74 \uc870\ub3c4 \ubc0f \uc815\ubc00\ub3c4\uac00 \ud544\uc694\ud569\ub2c8\ub2e4. \ub2e5\ud130 \uc218\uc758\uc0ac \uce58\ub8cc \ub808\uc774\uc800<\/a>. \uc774 \uae30\uc0ac\uc5d0\uc11c\ub294 \uc2e0\uc7a5 PBM\uc758 \uc0dd\ub9ac\uc801 \uba54\ucee4\ub2c8\uc998, \uc694\ucd94 \uacbd\uc720 \uce68\ud22c\uc758 \ubb3c\ub9ac\ud559, \uc804\uc2e0 \uad11\uc120 \uc694\ubc95\uc744 \ub178\uc778 \ub0b4\uacfc\uc5d0 \uc804\ub7b5\uc801\uc73c\ub85c \ud1b5\ud569\ud558\ub294 \ubc29\ubc95\uc744 \uc0b4\ud3b4\ubd05\ub2c8\ub2e4.<\/p>\n\n\n\n

\ubbf8\ud1a0\ucf58\ub4dc\ub9ac\uc544 \uc0dd\uccb4 \uc5d0\ub108\uc9c0 \ubc0f \uc2e0\uc7a5 \uc138\ud3ec \ubcf4\ud638<\/h3>\n\n\n\n

The renal system is characterized by an exceptionally high metabolic demand, particularly within the proximal convoluted tubules. These cells rely heavily on oxidative phosphorylation to drive the active transport mechanisms required for solute reabsorption and waste excretion. In the progression of CKD, mitochondrial dysfunction precedes the clinical elevation of Creatinine and Symmetric Dimethylarginine (SDMA). This “metabolic stall” leads to increased production of Reactive Oxygen Species (ROS) and a subsequent decline in Adenosine Triphosphate (ATP) availability.<\/p>\n\n\n\n

\uc804\ubb38\uac00\ub97c \ud1b5\ud55c \uc77c\uad00\ub41c \uc870\uba85 \ub3c4\uc785 \uc218\uc758\ud559 \ub808\uc774\uc800<\/a> \ub294 \ubd84\uc790 \uc218\uc900\uc5d0\uc11c \uc774\ub7ec\ud55c \uc5d0\ub108\uc9c0 \uacb0\ud54d\uc744 \ud574\uacb0\ud569\ub2c8\ub2e4. \uadfc\uc801\uc678\uc120 \uc2a4\ud399\ud2b8\ub7fc(810nm \ubc0f 1064nm)\uc758 \uad11\uc790\uac00 \uc2e0\uc7a5 \uc2e4\uc9c8\uc5d0 \ub3c4\ub2ec\ud558\uba74 \uc2dc\ud1a0\ud06c\ub86c C \uc0b0\ud654\ud6a8\uc18c(CCO)\uc5d0 \ud761\uc218\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc0c1\ud638 \uc791\uc6a9\uc740 \ubbf8\ud1a0\ucf58\ub4dc\ub9ac\uc544 \ud638\ud761 \uc0ac\uc2ac\uc5d0\uc11c \uc0b0\ud654\uc9c8\uc18c(NO)\uc758 \ud574\ub9ac\ub97c \ucd09\uc9c4\ud558\uc5ec \uc0b0\uc18c\uac00 \ub2e4\uc2dc \uacb0\ud569\ud558\uc5ec \ubbf8\ud1a0\ucf58\ub4dc\ub9ac\uc544 \ub9c9 \uc804\uc704\ub97c \ud68c\ubcf5\ud560 \uc218 \uc788\ub3c4\ub85d \ud569\ub2c8\ub2e4.<\/p>\n\n\n\n

Beyond ATP production, renal PBM exerts a potent anti-fibrotic effect. Chronic inflammation in the kidney is often driven by the TGF-beta signaling pathway, which promotes the transition of healthy tubular cells into myofibroblasts, leading to interstitial fibrosis. High-intensity PBM has been shown to modulate these signaling pathways, favoring a regenerative M2 macrophage phenotype over the pro-inflammatory M1 phenotype. For clinicians, this means the potential not only to manage pain but to slow the structural degradation of the kidney\u2014a feat that was previously considered unattainable with traditional pharmaceutical management alone.<\/p>\n\n\n\n

\uc694\ucd94 \uc7a5\ubcbd \uadf9\ubcf5\ud558\uae30: \uc2ec\ubd80 \uc7a5\uae30 \uce68\ud22c\uc758 \ubb3c\ub9ac\ud559<\/h3>\n\n\n\n

\uc7ac\ud0dd\uadfc\ubb34\ub97c \ud558\ub294 \uc8fc\ub41c \uc774\uc720\ub294 \ub808\ub4dc \ub77c\uc774\ud2b8 \ud14c\ub77c\ud53c \ubc18\ub824\ub3d9\ubb3c<\/a> devices fail in managing internal organ disease is a lack of irradiance. The kidneys of a canine patient are situated deep within the retroperitoneal space, shielded by the thick paraspinal muscles (longissimus dorsi and iliocostalis). To deliver a therapeutic dose\u2014calculated as the “Density of Dose” at the target tissue\u2014the laser must overcome significant scattering and absorption coefficients.<\/p>\n\n\n\n

\ub300\ubd80\ubd84\uc758 \uc77c\ubc18 \uc18c\ube44\uc790\uc6a9 \uae30\uae30\ub294 \ube44\ucf54\ud788\uc5b4\ub7f0\ud2b8 LED\ub97c \uc0ac\uc6a9\ud569\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uae30\uae30\ub294 \ud45c\uc7ac\uc131 \ud53c\ubd80 \uc9c0\uc6d0\uc744 \uc704\ud55c \ucd5c\uace0\uc758 \ubc18\ub824\uacac\uc6a9 \uc801\uc0c9\uad11 \uce58\ub8cc \uae30\uae30\ub85c \ud310\ub9e4\ub420 \uc218 \uc788\uc9c0\ub9cc, \uc694\ucd94 \uadfc\ub9c9\uc744 \uad00\ud1b5\ud558\ub294 \ub370 \ud544\uc694\ud55c \ucf5c\ub9ac\uba54\uc774\uc158\uc774 \ubd80\uc871\ud569\ub2c8\ub2e4. \uc218\uc758\uc0ac \uce58\ub8cc \ub808\uc774\uc800, \ud2b9\ud788 \ud074\ub798\uc2a4 4 \uc2dc\uc2a4\ud15c\uc740 \uc0dd\ubb3c\ud559\uc801 \uc7a5\ubcbd\uc744 \ud1b5\uacfc\ud560 \ub54c \ubb34\uacb0\uc131\uc744 \uc720\uc9c0\ud558\ub294 \ucf54\ud788\uc5b4\ub7f0\ud2b8 \ube54\uc744 \uc0ac\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n\n\n\n

The choice of wavelength is equally critical for renal applications. While 810nm is the “gold standard” for stimulating CCO, the 1064nm wavelength is the “penetration specialist.” It possesses a lower scattering coefficient in dense muscle tissue, allowing a higher percentage of photons to reach the renal capsule. By utilizing a multi-wavelength approach, the clinician can ensure that the superficial tissues are not overheated while the deep renal parenchyma receives the requisite energy density to trigger a photochemical response.<\/p>\n\n\n\n

\uc804\ub7b5\uc801 \ud1b5\ud569: \ub178\uc778 \uc6f0\ub2c8\uc2a4 \ud504\ub85c\uadf8\ub7a8\uc758 \uccb4\uacc4\uc801 PBM<\/h3>\n\n\n\n

Integrating high-power PBM into internal medicine changes the economic and clinical value of a veterinary practice. CKD is often viewed as a “maintenance” condition where the veterinarian’s role is largely limited to dietary management and subcutaneous fluid administration. By introducing systemic veterinary photobiomodulation, the clinic offers a proactive, biologically active intervention.<\/p>\n\n\n

\n
\"\"<\/figure>\n<\/div>\n\n\n

\uc5f0\uc2b5 \uc18c\uc720\uc790\uc758 \uacbd\uc6b0, \uace0\ud488\uc9c8\uc758 \ub808\uc774\uc800 \uce58\ub8cc \uc7a5\ube44<\/a> for internal medicine provides a unique revenue stream. Patients with CKD require frequent monitoring and recurring therapy. A structured “Renal Support Protocol” involving twice-weekly laser sessions creates a high-touch environment where the clinical team can monitor the patient’s hydration, appetite, and mobility more closely.<\/p>\n\n\n\n

Furthermore, the systemic effects of PBM are profound. When the kidneys are treated, the light also interacts with the blood flowing through the large renal arteries. This “blood irradiation” effect helps modulate systemic inflammation, which is particularly beneficial for senior dogs suffering from the triad of CKD, osteoarthritis, and cognitive decline. This holistic benefit ensures high client compliance, as owners observe global improvements in their pet’s vitality, not just in their blood chemistry.<\/p>\n\n\n\n

\uc784\uc0c1 \uc0ac\ub840 \uc5f0\uad6c: \uc2dc\ub2c8\uc5b4 \ube44\uae00\uc758 IRIS 3\uae30 \ub9cc\uc131 \uc2e0\uc7a5 \uc9c8\ud658 \uad00\ub9ac<\/h3>\n\n\n\n

\uc774 \uc0ac\ub840 \uc5f0\uad6c\ub294 \uc2e4\ud328\ud55c \uc81c\uc57d \ubc0f \uc218\uc561 \ud504\ub85c\ud1a0\ucf5c\uc5d0\uc11c \uace0\ucd9c\ub825 \uc2e0\uc7a5 PBM\uc744 \ud1b5\ud569\ud55c \uba40\ud2f0\ubaa8\ub2ec \uc804\ub7b5\uc73c\ub85c \uc804\ud658\ud558\ub294 \uacfc\uc815\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<\/p>\n\n\n\n

\ud658\uc790 \ubc30\uacbd<\/strong><\/p>\n\n\n\n